INS and pancreatic insulinoma: While most studies observed the inhibitory effects of CB1R activation on insulin secretion, there is data suggesting stimulatory action of CB1R on insulin secretion by direct addition of endocannabinoids AEA and 2-AG and their synthetic analogs to human and mouse islet preparations (16, 21) and rodent insulinoma cells (22, 81).